Carisma Therapeutics Inc. Retained Earnings
Carisma Therapeutics Inc. had Retained Earnings of -$279.90 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-11-12
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$279.90M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$324.62M.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$314.85M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$305.58M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2025-09-30 | -$279.90M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$324.62M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$314.85M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | -$305.58M 10-Q · filed 2025-11-12 | |
| 2024-09-30 | -$287.94M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$275.24M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | -$264.08M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$245.10M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$224.14M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$202.74M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$182.87M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$158.22M 10-K · filed 2024-04-01 | -$336.14M 10-K · filed 2023-02-28 |
| 2022-09-30 | -$328.57M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | -$349.02M 10-Q/A · filed 2022-08-25 | |
| 2022-03-31 | -$317.06M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | -$316.26M 10-K · filed 2023-02-28 | |
| 2021-09-30 | -$325.20M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | -$396.88M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | -$371.43M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | -$315.92M 10-K · filed 2022-02-28 | |
| 2020-09-30 | -$300.91M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | -$278.30M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | -$251.96M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | -$293.52M 10-K · filed 2021-03-15 | |
| 2019-09-30 | -$259.97M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$246.84M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$192.50M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | -$186.02M 10-K · filed 2020-03-16 | |
| 2018-09-30 | -$179.27M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | -$165.25M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$156.29M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$152.33M 10-K · filed 2019-03-01 | |
| 2017-09-30 | -$145.78M 10-Q · filed 2017-11-17 | |
| 2017-06-30 | -$136.68M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$129.36M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | -$123.31M 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$119.78M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$139.27M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | -$132.78M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | -$125.20M 10-K · filed 2017-03-24 | |
| 2015-09-30 | -$114.87M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | -$105.18M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | -$98.27M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | -$91.75M 10-K · filed 2016-03-25 | |
| 2014-09-30 | -$83.61M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | -$72.94M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | -$64.82M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$57.59M 10-K · filed 2015-03-06 |